FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Early oral antiviral treatment in COVID-19 outpatients linked to 14% lower risk of long COVID and faster recovery after Omicron infection.
Read MoreEbola outbreak in eastern DRC causes 131 deaths, 513 cases; U.S. doctor infected as WHO and CDC increase monitoring efforts.
Read MoreWHO reports stalled global health progress with rising maternal and child mortality, HIV setbacks, and reversed gains in neglected tropical diseases.
Read MoreA 2026 study of 11,000 adults found hidden muscle fat linked to higher risks of heart disease and metabolic disorders, independent of body size.
Read MoreCMS announces a six-month nationwide moratorium on new Medicare enrollments for hospices and home health agencies starting May 13, 2026.
Read MoreResearchers found that gut-derived exosomes from older animals trigger inflammation and metabolic changes linked to aging and chronic disease.
Read MoreResearchers at NTNU found that 30 minutes of weekly high-intensity exercise can greatly improve heart health and reduce risks of premature death and diseases.
Read MoreThe CDC activated an emergency response in May 2026 after a hantavirus outbreak linked to a cruise ship, urging precautions while monitoring exposed travelers.
Read MoreA JAMA study found healthy infants have high blood levels of p-tau217, an Alzheimer’s biomarker, indicating a normal role in early development.
Read MoreThe AMA urged Congress to enact safety regulations for AI mental-health chatbots to address risks like misinformation and privacy breaches.
Read More